How Long Is LSD in Urine? Detection Windows & Factors

LSD is one of the hardest recreational drugs to catch on a standard urine test, mainly because the doses people take are extraordinarily small and the body breaks the drug down quickly. The parent compound has a half-life of roughly four hours and, within 24 hours, only about one percent of the ingested dose shows up in urine as unchanged LSD. Most routine workplace drug panels don’t even screen for it. When a test does target LSD specifically, the detection window in urine generally spans about one to three days after a single dose, though the exact timeframe hinges on the dose taken, the sensitivity of the test, and whether the lab also looks for LSD’s primary metabolite.

Why LSD Disappears From Urine So Quickly

A typical LSD dose ranges from roughly 50 to 200 micrograms, which is measured in millionths of a gram. That’s orders of magnitude smaller than the milligram-level doses of most other drugs. This tiny starting amount means the body doesn’t need to work very hard to clear it, and the concentrations in blood and urine are vanishingly low from the start.

Pharmacokinetic studies in healthy adults have measured LSD’s elimination half-life at about 3.6 to 4.0 hours during the first 12 hours after dosing, with a slower terminal phase of roughly 9 hours for whatever drug remains after that initial clearance period.¹ After a single oral dose, peak blood concentrations happen within about 1.5 to 2 hours, and the subjective effects wear off within roughly 8 to 12 hours. But the drug leaves the bloodstream well before the experience fully fades, which is part of why the urine window is so short.

Only about one percent of an administered dose is recovered from urine as unchanged LSD within the first 24 hours.² To put that in concrete terms, if someone takes 100 micrograms, only about one microgram ends up in urine as the parent drug. That’s a staggeringly small amount to detect, and it explains why LSD demands much more sensitive testing equipment than, say, cannabis or amphetamines.

The Metabolite That Extends the Window

The body converts most LSD into a metabolite called 2-oxo-3-hydroxy-LSD, often abbreviated O-H-LSD. About 13 to 16 percent of the dose is excreted in urine as this metabolite within 24 hours, making it far more abundant than the parent drug.¹² In most LSD-positive urine samples, O-H-LSD is present at higher concentrations than LSD itself and can be detected for a longer period after ingestion.³

This matters because modern forensic labs increasingly test for O-H-LSD alongside the parent drug. A test that only looks for unchanged LSD might miss a positive result after 24 to 48 hours. A test that also targets the metabolite can push the detection window out further, sometimes to 72 hours or slightly beyond. If you’ve seen claims online that LSD is detectable for “up to five days,” those estimates usually assume a higher-than-average dose combined with a lab that screens for the metabolite using a highly sensitive technique.

How Testing Methods Shape the Detection Window

Not all LSD tests are created equal, and the method used has an outsized effect on whether a sample comes back positive.

Standard immunoassay-based screening panels, the kind used in many workplace drug tests, weren’t originally designed for LSD. Many of the common panels that test for a handful of drug classes (often called “5-panel” or “10-panel” tests) don’t include LSD at all. When an immunoassay does target LSD, the cutoff concentration is typically set at 0.5 ng/mL or sometimes as low as 0.2 ng/mL. Given that urinary LSD concentrations are often in the sub-nanogram range even shortly after dosing, an immunoassay with a 0.5 ng/mL cutoff has a narrow window of maybe 8 to 24 hours, depending on the dose.

Confirmatory testing uses more sensitive techniques. Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) can push detection limits down to 0.025 ng/mL for LSD, which is twenty times more sensitive than the older immunoassay standard.⁴ Validated LC-MS/MS methods now exist for simultaneously quantifying both LSD and O-H-LSD in urine at concentrations as low as 10 pg/mL (picograms per milliliter).³⁵ At those sensitivity levels, detection windows stretch meaningfully longer. This is the gap between what a standard workplace screen can catch and what a forensic laboratory, military testing program, or criminal investigation can detect.

Factors That Make the Window Shorter or Longer

Several variables influence how long LSD or its metabolite remains detectable in your urine.

Dose: This is the most straightforward factor. A higher dose means more drug and more metabolite entering the urine. Urinary recovery of O-H-LSD is dose-proportional, so doubling the dose roughly doubles the amount excreted.² Someone who takes 200 micrograms will have a detectably longer window than someone who takes 50.
Hydration and urine output: More dilute urine spreads the same amount of drug over a larger volume, lowering the concentration per milliliter. If you’re well-hydrated and urinating frequently, concentrations in any single sample drop faster. Conversely, dehydrated urine concentrates the drug.
Metabolic enzymes: LSD is broken down by several liver enzymes, including CYP2D6, CYP3A4, CYP1A2, and others. Genetic differences in these enzymes vary substantially across individuals, and researchers have noted that genetic polymorphisms and drug interactions could influence how quickly LSD is metabolized.⁶ People who metabolize drugs faster through these pathways will clear LSD more quickly, and vice versa.
Other medications: Because multiple liver enzymes are involved, drugs that either inhibit or induce those enzymes can shift the timeline. In lab experiments, the antibiotic rifampicin, a potent enzyme inducer, distinctly sped up LSD metabolism.⁶ Enzyme inhibitors could theoretically slow it down, though this hasn’t been well-studied in humans with LSD specifically.
Body composition and age: General pharmacokinetic principles apply. Older adults and people with reduced liver or kidney function tend to clear drugs more slowly, which could extend the detection window. However, controlled LSD pharmacokinetic studies have mostly been conducted in healthy younger adults, so data on these edge cases is thin.

False Positives From Common Medications

Immunoassay screens for LSD are known to cross-react with certain medications, producing false positives in people who have never taken LSD. This issue is specific to the initial screening step. Confirmatory mass spectrometry testing will distinguish LSD from these interfering substances, but the false positive itself can cause unnecessary alarm, especially in a workplace or clinical setting.

Several antidepressants are the most common culprits. The SSRI sertraline has been reported to cause false-positive results for LSD, as has fluoxetine. Among older-generation medications, amitriptyline, desipramine, doxepin, and imipramine have also been linked to false LSD results on immunoassay screens. Bupropion and trazodone round out the list of known offenders.⁷ If you take any of these medications and face an LSD-positive immunoassay result, requesting a confirmatory test with mass spectrometry is the appropriate next step. A legitimate positive for LSD will be confirmed; a cross-reaction from medication will not.

Why Sample Handling Matters More Than You’d Think

LSD is an unusually fragile molecule. It degrades under light, heat, and certain pH conditions, and this instability creates a practical problem: a urine sample that was genuinely positive at the time of collection can test negative later if the sample isn’t stored properly.

Stability studies have shown that LSD in urine is reasonably stable at room temperature (about 25°C) for up to four weeks with no significant loss. But at body temperature (37°C), roughly 30 percent of the LSD degrades after four weeks, and at 45°C the loss climbs to about 40 percent.⁸ Light exposure is the other major threat. Urine stored in amber glass or opaque containers showed no change in LSD concentration under any light conditions, while transparent containers allowed degradation that depended on light intensity, wavelength, and distance from the light source.⁸

For practical purposes, this means that a sample collected in a clear plastic cup, left sitting in a bright room for hours before being shipped to a lab, could lose enough LSD to drop below the detection threshold. Proper forensic and clinical protocols call for refrigerated storage in opaque containers, but not every collection site follows ideal procedures. This is one underappreciated reason why LSD can be missed on a drug test even when it was genuinely present in the person’s system.

Can Adulterants Beat an LSD Test?

Some people attempt to adulterate their urine with household chemicals to defeat drug tests. Researchers have tested 15 different chemicals and household agents for their effect on the enzyme immunoassay used to screen for LSD. While some adulterants at high concentrations (10 percent by volume) caused false positives, none of them were able to conceal the presence of LSD in a spiked sample, meaning they didn’t produce false negatives.⁹ Most of these adulterants were also detectable through simple checks like pH measurement, specific gravity testing, and visual inspection of the sample. So the immunoassay, when combined with basic sample integrity checks and a confirmatory method, is a robust approach for detecting LSD despite adulteration attempts.

LSD Analogs and Prodrugs in Urine Testing

The past decade has seen the emergence of several LSD-related compounds sold as “research chemicals” or designer drugs. Substances like 1P-LSD, ALD-52, and 1B-LSD are structurally modified versions of LSD, and their relationship to urine testing is worth understanding.

In the body, several of these analogs are converted back into LSD itself. Laboratory studies have confirmed that ALD-52, 1P-LSD, and 1B-LSD all undergo deacylation, meaning the chemical modification is stripped off to yield plain LSD as a metabolite.¹⁰ This makes them effectively prodrugs: you ingest the analog, and your liver converts it to LSD. From the perspective of a urine test, this means someone who took 1P-LSD can produce a sample that tests positive for LSD.

Case data supports this. In one documented intoxication involving 1P-LSD, the laboratory found LSD in both the patient’s urine and serum, while 1P-LSD itself was undetectable. The researchers concluded that rapid conversion to LSD in the body was the most likely explanation, rather than the 1P-LSD simply degrading in the sample tubes.¹¹ That said, some temperature-dependent conversion of 1P-LSD to LSD was also observed in stored samples, with up to 21 percent converting in serum stored at room temperature.¹¹ This creates an added layer of complexity for forensic labs trying to determine exactly which substance was originally consumed.

Not all LSD analogs convert to LSD, though. Some produce structurally distinct metabolites that wouldn’t trigger a standard LSD immunoassay, which is an active area of research in forensic toxicology.

How LSD Compares to Other Matrices

Urine is the most common specimen for LSD testing, but it isn’t the only option. Blood (or serum) testing can detect LSD, though the window is generally shorter than urine because blood concentrations fall rapidly after the first few hours. Hair testing theoretically offers a much longer detection window of weeks to months, as with other drugs, but LSD’s extremely low dose makes reliable hair detection difficult and poorly standardized. Oral fluid (saliva) has been explored as a less invasive alternative, though published validation data remains limited.

Each matrix has trade-offs. Blood is the most useful when the question is whether someone is currently under the influence, since blood levels correlate more directly with acute effects. Urine is the practical choice for detecting use within the past one to three days. Hair is the option for longer lookback periods but comes with significant analytical challenges given the minuscule quantities involved. Research continues into improving methods across all of these sample types, with particular focus on reducing detection limits and improving reliability for forensic casework.

When LSD Testing Actually Happens

Despite all of these detection capabilities, LSD testing is far less common than testing for drugs like cannabis, opioids, cocaine, or amphetamines. Standard workplace panels don’t include it. Military testing programs, federal employee screening for sensitive positions, and certain clinical or forensic scenarios are the most common situations where LSD-specific testing is ordered. Hospital emergency departments may test for LSD when a patient presents with symptoms suggesting hallucinogen intoxication, but even then, the diagnosis is often made clinically rather than through a confirmatory lab result, because the test turnaround time usually exceeds the duration of the drug’s effects.

For people in microdosing communities who take very low amounts (often 10 to 20 micrograms), the detection window is shorter still, because the already tiny urinary concentrations drop below even the most sensitive detection thresholds more rapidly. A 10-microgram microdose might be undetectable in urine within 12 to 24 hours, depending on the assay. However, clinical data on microdose-level urinary pharmacokinetics is sparse, so this is an educated inference from the dose-proportional excretion patterns documented in studies using standard doses rather than a firmly established number.